Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Treasury Shares (2017 - 2024)

Historic Treasury Shares for Assembly Biosciences (ASMB) over the last 9 years, with Q4 2024 value amounting to $68054.0.

  • Assembly Biosciences' Treasury Shares fell 2850.12% to $68054.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $68054.0, marking a year-over-year decrease of 2850.12%. This contributed to the annual value of $68054.0 for FY2024, which is 2850.12% down from last year.
  • According to the latest figures from Q4 2024, Assembly Biosciences' Treasury Shares is $68054.0, which was down 2850.12% from $95182.0 recorded in Q4 2023.
  • Assembly Biosciences' Treasury Shares' 5-year high stood at $1.8 million during Q3 2022, with a 5-year trough of $68054.0 in Q4 2024.
  • Over the past 5 years, Assembly Biosciences' median Treasury Shares value was $980964.0 (recorded in 2020), while the average stood at $929721.0.
  • Over the last 5 years, Assembly Biosciences' Treasury Shares had its largest YoY gain of 10281.27% in 2022, and its largest YoY loss of 8541.29% in 2022.
  • Quarter analysis of 5 years shows Assembly Biosciences' Treasury Shares stood at $886868.0 in 2020, then increased by 9.41% to $970339.0 in 2021, then plummeted by 85.41% to $141544.0 in 2022, then tumbled by 32.75% to $95182.0 in 2023, then fell by 28.5% to $68054.0 in 2024.
  • Its last three reported values are $68054.0 in Q4 2024, $95182.0 for Q4 2023, and $141544.0 during Q4 2022.